Introduction: Recent studies have suggested that cannabidiol (CBD) could interconvert into Delta-8- and Delta-9- tetrahydrocannabinol. Materials and Methods: Thus, we tested the plasma samples of 120 healthy human subjects (60 male and 60 female), 60 in fasting and the other 60 under normal feeding conditions after acute administration of an oral solution containing CBD 300 mg. To do this, we developed a bioanalytical method to determine CBD and the presence of THC in plasma samples by Ultra-High Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry. Results: The results showed that THC was not detected in plasma after the administration of CBD, and those study participants did not present psychotomimetic effects. Conclusions: The findings presented here are consistent with previous evidence suggesting that the oral administration of CBD in a corn oil formulation is a safe route for the administration of the active substance without bioconversion to THC in humans. Copyright 2020, Mary Ann Liebert, Inc., publishers.
Introduction: Recent studies have suggested that cannabidiol (CBD) could interconvert into Delta-8- and Delta-9- tetrahydrocannabinol. Materials and Methods: Thus, we tested the plasma samples of 120 healthy human subjects (60 male and 60 female), 60 in fasting and the other 60 under normal feeding conditions after acute administration of an oral solution containing CBD 300 mg. To do this, we developed a bioanalytical method to determine CBD and the presence of THC in plasma samples by Ultra-High Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry. Results: The results showed that THC was not detected in plasma after the administration of CBD, and those study participants did not present psychotomimetic effects. Conclusions: The findings presented here are consistent with previous evidence suggesting that the oral administration of CBD in a corn oil formulation is a safe route for the administration of the active substance without bioconversion to THC in humans. Copyright 2020, Mary Ann Liebert, Inc., publishers.
Entities:
Keywords:
UHPLC-ESI-MS/MS; cannabidiol; delta-8-tetrahydrocannabinol; delta-9-tetrahydrocannabinol; interconversion; pharmacokinetics; protein precipitation
Authors: Orrin Devinsky; J Helen Cross; Linda Laux; Eric Marsh; Ian Miller; Rima Nabbout; Ingrid E Scheffer; Elizabeth A Thiele; Stephen Wright Journal: N Engl J Med Date: 2017-05-25 Impact factor: 91.245
Authors: Alexandre R de Mello Schier; Natalia P de Oliveira Ribeiro; Danielle S Coutinho; Sergio Machado; Oscar Arias-Carrión; Jose A Crippa; Antonio W Zuardi; Antonio E Nardi; Adriana C Silva Journal: CNS Neurol Disord Drug Targets Date: 2014 Impact factor: 4.388
Authors: Orrin Devinsky; Anup D Patel; J Helen Cross; Vicente Villanueva; Elaine C Wirrell; Michael Privitera; Sam M Greenwood; Claire Roberts; Daniel Checketts; Kevan E VanLandingham; Sameer M Zuberi Journal: N Engl J Med Date: 2018-05-17 Impact factor: 91.245
Authors: M H N Chagas; A L Eckeli; A W Zuardi; M A Pena-Pereira; M A Sobreira-Neto; E T Sobreira; M R Camilo; M M Bergamaschi; C H Schenck; J E C Hallak; V Tumas; J A S Crippa Journal: J Clin Pharm Ther Date: 2014-05-21 Impact factor: 2.512
Authors: Ila M Linares; Antonio W Zuardi; Luis C Pereira; Regina H Queiroz; Raphael Mechoulam; Francisco S Guimarães; José A Crippa Journal: Braz J Psychiatry Date: 2018-10-11 Impact factor: 2.697
Authors: Antonio Waldo Zuardi; Jose Alexandre S Crippa; Jaime E C Hallak; Sagnik Bhattacharyya; Zerrin Atakan; Rocio Martin-Santos; Philip K McGuire; Francisco Silveira Guimarães Journal: Curr Pharm Des Date: 2012 Impact factor: 3.116
Authors: Danielle McCartney; Richard C Kevin; Anastasia S Suraev; Christopher Irwin; Ronald R Grunstein; Camilla M Hoyos; Iain S McGregor Journal: Drug Test Anal Date: 2021-08-30 Impact factor: 3.234